標(biāo)題: Titlebook: Natural Product-based Synthetic Drug Molecules in Alzheimer‘s Disease; Therapeutic & Theran Abha Sharma,Gyan Prakash Modi Book 2023 The Edi [打印本頁] 作者: HABIT 時間: 2025-3-21 16:25
書目名稱Natural Product-based Synthetic Drug Molecules in Alzheimer‘s Disease影響因子(影響力)
書目名稱Natural Product-based Synthetic Drug Molecules in Alzheimer‘s Disease影響因子(影響力)學(xué)科排名
書目名稱Natural Product-based Synthetic Drug Molecules in Alzheimer‘s Disease網(wǎng)絡(luò)公開度
書目名稱Natural Product-based Synthetic Drug Molecules in Alzheimer‘s Disease網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Natural Product-based Synthetic Drug Molecules in Alzheimer‘s Disease被引頻次
書目名稱Natural Product-based Synthetic Drug Molecules in Alzheimer‘s Disease被引頻次學(xué)科排名
書目名稱Natural Product-based Synthetic Drug Molecules in Alzheimer‘s Disease年度引用
書目名稱Natural Product-based Synthetic Drug Molecules in Alzheimer‘s Disease年度引用學(xué)科排名
書目名稱Natural Product-based Synthetic Drug Molecules in Alzheimer‘s Disease讀者反饋
書目名稱Natural Product-based Synthetic Drug Molecules in Alzheimer‘s Disease讀者反饋學(xué)科排名
作者: 出血 時間: 2025-3-21 20:18
Oxidative Stress and Metals in Alzheimer’s Diseasefects the elderly population. Key pathological hallmarks of AD are extracellular depositions of beta-amyloid plaques, intracellular accumulation of neurofibrillary tangles (NFTs), and alterations in amyloid precursor protein (APP) gene, and it is clinically characterised by changes in cellular and m作者: Nonconformist 時間: 2025-3-22 03:51
Neuroinflammation in Alzheimer’s Diseaseelderly individuals. Mild-to-severe extent of neurodegeneration triggers AD in most cases. Patients with AD carry a higher chance of generation of dementia, memory loss, and gradual loss of basic intellect. According to a recent report, calcium dysfunction at the neuron level and microglia-mediated 作者: 頑固 時間: 2025-3-22 06:00 作者: Medicare 時間: 2025-3-22 11:59 作者: neolith 時間: 2025-3-22 14:35 作者: babble 時間: 2025-3-22 19:51
Approved Cholinesterase Inhibitor-Based Derivatives: Synthesis and Their Biological Evaluationchers. Alzheimer’s disease (AD) is one such disease that involves multiple largely ambiguous pathophysiological pathways, which makes it a challenging thrust area of research around the globe. The current approved drugs for the management of the disease include rivastigmine, donepezil, galantamine (作者: 鍵琴 時間: 2025-3-23 00:06 作者: 教唆 時間: 2025-3-23 03:48 作者: heartburn 時間: 2025-3-23 08:19
Polyphenol: Development of Polyphenol-Inspired Derivatives Targeting Pathological Factors of ADs. Polyphenolic compounds, a class of natural plant compounds, have been extensively studied for their potential therapeutic use in AD. The neuroprotective, antioxidant, as well as anti-inflammatory properties exhibited by these compounds are important in the treatment and management of AD. Phenolic作者: 亞當(dāng)心理陰影 時間: 2025-3-23 13:18 作者: Congestion 時間: 2025-3-23 14:22 作者: FLOUR 時間: 2025-3-23 19:39 作者: BAIT 時間: 2025-3-23 23:04 作者: TOXIC 時間: 2025-3-24 05:32 作者: 發(fā)酵劑 時間: 2025-3-24 07:00
thenticator is a standard type of “universal” hash function providing information-theoretic security; what is new is computing this type of hash function at very high speed..At a lower level, this paper shows how to multiply two elements of a field of size . using just . bit operations, and how to m作者: Immortal 時間: 2025-3-24 14:20 作者: TOM 時間: 2025-3-24 15:08 作者: Onerous 時間: 2025-3-24 20:28 作者: ALOFT 時間: 2025-3-25 02:24
dentials on attributes and prove possession of these credentials in an unlinkable fashion while revealing only a subset of the attributes. In practice, .s typically need additional features like revocation, pseudonyms as privacy-friendly user public keys, or advanced issuance where attributes can be作者: 步兵 時間: 2025-3-25 03:25 作者: ferment 時間: 2025-3-25 11:32 作者: constellation 時間: 2025-3-25 13:34
Teeja Suthar,Keerti Jainsignature schemes use a . in the computation of each signature and the knowledge of this nonce is sufficient to fully recover the secret key of the scheme. Even a few bits of the nonce over several signatures allow a complete break of the scheme by lattice-based attacks. Several works have investiga作者: 多產(chǎn)魚 時間: 2025-3-25 18:09
curity protection for AES-128. By combining both 1st-order masking and shuffling techniques, improved RSM claims to offer at least non-profiled resistance for its software implementation and up?to now no systematic research has been published to challenge such security claim yet. To study the practi作者: 墊子 時間: 2025-3-25 23:51 作者: Inkling 時間: 2025-3-26 02:35 作者: Lipoma 時間: 2025-3-26 07:11 作者: relieve 時間: 2025-3-26 12:13
Vedika G. Dadlani,Harshal Ashok Pawar,Pushpendra K. Tripathisignature schemes use a . in the computation of each signature and the knowledge of this nonce is sufficient to fully recover the secret key of the scheme. Even a few bits of the nonce over several signatures allow a complete break of the scheme by lattice-based attacks. Several works have investiga作者: minaret 時間: 2025-3-26 12:53 作者: intolerance 時間: 2025-3-26 18:49
Jyoti Pandeynnel resilience is still poorly understood. Aysu et al.?(HOST’18) recently investigated single-trace attacks against the core lattice operation, namely multiplication between a public matrix and a “small” secret vector, in the context of a . implementation. We complement this work by considering sin作者: 不可侵犯 時間: 2025-3-26 23:54 作者: Diuretic 時間: 2025-3-27 03:15
sed, code-based, and lattice-based cryptography. Moreover, we revisit and expand on a transformation by Szepieniec?.?[.] to shrink the public key at the cost of a larger signature while reducing their combined size. This transformation can be used in a way that is provably secure in the random oracl作者: HUMP 時間: 2025-3-27 08:53
Bhaskar Dewangan,Kunal Kumar,Amit Kumar,Praveen Reddy Bodhe,Sunita Beni,Bichismita Sahubound on probability of single differential characteristics. However, already at EUROCRYPT’91, Lai et al. comprehended that differential cryptanalysis rather uses . instead of single ...In this paper, we consider exactly the gap between these two approaches and investigate this gap in the context of作者: 我就不公正 時間: 2025-3-27 10:23
Gourav Singh,Nishant Kumar Rana,Indubhusan Mishra,Gyan Prakash Modin AES-like one, it seems (rather) hard to exploit such a distinguisher in order to implement a key-recovery attack different than brute-force like. On the other hand, such result has been exploited to set up a new (competitive) secret-key distinguisher for 4-round AES, called “Mixture Differential C作者: expdient 時間: 2025-3-27 17:38
Alzheimer’s Disease and Drug Targetsause severe side effects, and may cause the death of patients. Hence, new agents are required to target the disease at different levels or more than one level for the management of AD. The published pieces of literature show that inhibition of Aβ formation, degradation or disaggregation of Aβ plaque作者: Blemish 時間: 2025-3-27 17:49 作者: corn732 時間: 2025-3-28 01:13
Neuroinflammation in Alzheimer’s Diseaset none of the existing and new drug candidates proved to have potent disease-curing activity. This chapter deals mainly with the role of neuroinflammation in the disease progression of AD. The effect of injury, immunity, infection, and aging on neuroinflammation is described in detail. Further, the 作者: abracadabra 時間: 2025-3-28 05:10 作者: Detoxification 時間: 2025-3-28 09:20
Fluorescent Organic Molecules as Diagnostic and Theranostic Tools for Alzheimer’s Diseaseliver diagnosis and therapy simultaneously, which is entitled as “theranostics”. A theranostic agent is one that has both therapeutic and diagnostic qualities. Unlike the typical therapeutic method, in which two distinct drugs serve as deputies to achieve two different objectives, theranostic agents作者: 積極詞匯 時間: 2025-3-28 12:43 作者: Demonstrate 時間: 2025-3-28 16:11 作者: elucidate 時間: 2025-3-28 21:58
Huperzine-Based Derivatives: Design, Synthesis, and Anti-Alzheimer Activityaches, and multipotent naturally occurring agents have recently drawn attention in this regard. Huperzine A, derived from . is one amongst these. Chemically, it is an alkaloid containing quinolizidine with good potency and selectivity and reversible inhibition of acetylcholinesterase. Many analogs o作者: 談判 時間: 2025-3-29 01:25
Polyphenol: Development of Polyphenol-Inspired Derivatives Targeting Pathological Factors of ADch can help to improve cognitive function in AD patients. Due to their potential therapeutic efficacy, polyphenols are a key focus in medicinal chemistry for designing multi-targeted as well as single-targeted drug ligands against different therapeutic targets of AD. In this chapter, we have aimed t作者: 歡呼 時間: 2025-3-29 05:53
Vitamin-Based Derivatives for the Management of Alzheimer’s Diseasehat show potential to treat Alzheimer’s disease. Primarily these compounds act on nuclear receptors to activate ADAM10, inhibiting AChE or BuChE, neutralisation of ROS, inhibition of GSK-3, and amyloid-beta aggregation. Moreover, some can easily pass the BBB, which is crucial in targeting neurologic作者: pantomime 時間: 2025-3-29 11:10 作者: 可耕種 時間: 2025-3-29 13:27 作者: Misgiving 時間: 2025-3-29 17:17 作者: incision 時間: 2025-3-29 20:36
Natural Product-based Synthetic Drug Molecules in Alzheimer‘s DiseaseTherapeutic & Theran作者: 譏諷 時間: 2025-3-30 02:19
Natural Product-based Synthetic Drug Molecules in Alzheimer‘s Disease978-981-99-6038-5作者: 舉止粗野的人 時間: 2025-3-30 08:08 作者: Muscularis 時間: 2025-3-30 10:08
s for constant-time implementations of GHASH without PCLMULQDQ (over 10 cycles/byte), even faster than Intel’s best Sandy Bridge implementation of GHASH with PCLMULQDQ (1.79 cycles/byte), and almost as fast as state-of-the-art 128-bit prime-field MACs using Intel’s integer-multiplication hardware (a作者: sinoatrial-node 時間: 2025-3-30 15:24 作者: Angiogenesis 時間: 2025-3-30 18:12 作者: 魯莽 時間: 2025-3-31 00:05
Santanu Kaity,Anoop Kumarrevious efforts, our definitions are not targeted at one specific use-case; rather, we try to capture generic properties that can be useful in a variety of scenarios. We believe that our definitions can also be used as a starting point for diverse application-dependent extensions and variations of .作者: cancer 時間: 2025-3-31 02:39
revious efforts, our definitions are not targeted at one specific use-case; rather, we try to capture generic properties that can be useful in a variety of scenarios. We believe that our definitions can also be used as a starting point for diverse application-dependent extensions and variations of .作者: 結(jié)果 時間: 2025-3-31 06:59
Mareechika Gaddam,Esther Rani Motamarri,Abha Sharmaand where to place them in the circuit. Our method is mainly based on linear programming. Our result can advantageously be applied to existing constructions. As an example, we show that for the Smart-Tillich AES circuit, published on the Internet in 2012, we find about 70?% less bootstrappings than 作者: 軟弱 時間: 2025-3-31 11:05
Kondakamarla Imran,Yashasvi Anant Dhamapurkar,Abha Sharmaand where to place them in the circuit. Our method is mainly based on linear programming. Our result can advantageously be applied to existing constructions. As an example, we show that for the Smart-Tillich AES circuit, published on the Internet in 2012, we find about 70?% less bootstrappings than 作者: MOTIF 時間: 2025-3-31 16:03
